• Rushil V Patel, Fatima Ali, Zane Chiad, Aleksander L Chojecki, Jason A Webb, William E Rosa, and Thomas W LeBlanc.
• Division of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
• J Palliat Med. 2024 Jun 1; 27 (6): 794801794-801.

AbstractAcute myeloid leukemia (AML) is the most common form of acute leukemia in adults. Rapidly proliferating leukemic cells cause symptoms and increase the risk of infection. While individuals may initially benefit from supportive measures, disease-directed therapy may ultimately be required for symptom management, even at the end of life, although this may also inadvertently increase symptom burden. This unpredictable illness trajectory complicates prognostic uncertainty and the timing of hospice referral, which may prohibit access to palliative therapies and lead to recurrent hospitalizations. However, emerging evidence demonstrates that early palliative care (PC) integration with standard leukemia care results in improved quality of life, psychological outcomes, and greater participation in advance care planning. To orient PC clinicians asked to care for patients with AML, this article highlights 10 salient considerations.

14 keywords...

hide…